Trials Sponsors Conditions Drugs Pricing

Conditions

Minimally Invasive Distal Pancreatectomy

Keywords

Benign or borderline pathology (non-pancreatic cancer)laparoscopyregistrarpostoperative outcomespancreatectomysurgerypancreas

Outcome Measures

Primary Outcomes (1)

open conversion rate
Necessity to swith from minimally invasive approach to open approach during laparoscopy
1 day

Secondary Outcomes (9)

Duration of surgery
1 day
Intraoperative bloodloss
1 day
Intraoperative transfusion
1 day
severe complications Clavien Dindo>3
90 days postoperative
postoperative complications
90 days postoperative
+4 more secondary outcomes

Study Arms (2)

Group 1 (Registrar)

Group 1 (Registrar): Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology operated on by a registrar (young specialist surgeon)

Procedure: Minimally invasive distal pancreatectomy

Group 2 (Consultant)

Group 2 (Consultant): Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology operated on by a consultant (expert)

Procedure: Minimally invasive distal pancreatectomy

Interventions

Minimally invasive distal pancreatectomyProcedure

Minimally invasive distal pancreatectomy

Group 1 (Registrar)Group 2 (Consultant)

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 99 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology

You may qualify if:

\- Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology between 2009-2020

You may not qualify if:

Sponsors & Collaborators

University Hospital, Montpellier
Otherlead

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Study Officials

REGIS SOUCHE
University Hospital, Montpellier
STUDY DIRECTOR

Enrollment

71 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

June 9, 2020

First Posted

June 12, 2020

Study Start

December 1, 2019

Actual (reported)

Registrar Performances in MIDP

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (9)

Study Arms (2)

Group 1 (Registrar)

Group 2 (Consultant)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (9)

Study Arms (2)

Group 1 (Registrar)

Group 2 (Consultant)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations